Literature DB >> 7540258

Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies.

W Trojaborg1, A P Hays, L van den Berg, D S Younger, N Latov.   

Abstract

We measured residual latency (RL), motor conduction velocity (MCV), and terminal latency index (TLI) in 15 patients with neuropathy and anti-MAG or SGPG antibodies and compared these to values obtained in 103 patients with other types of polyneuropathy (PN) and to 57 normal subjects. Ten patients had anti-MAG antibody titers of 25,600 or higher, and 5 had titers between 800 and 12,600. Patients with the highest titers had longer RL, slower MCV and shorter TLI than those with lower titers, acute or chronic inflammatory demyelinating PN, hereditary neuropathy, and metabolic or axonal neuropathy. In contrast F-wave latencies did not contribute to the differentiation between the groups of demyelinating neuropathies. RL and TLI correlated best with anti-MAG antibody titers, whereas there was a poor correlation with anti-SGPG titers suggesting that MAG more than SGPG may be the antigen in PN, and that the distal nerves are affected more than their proximal segments. The RL rather than TLI turned out to be the best variable to classify the demyelinating type of anti-MAG neuropathy. Sural nerve biopsy in 5 of the patients with the highest titer of anti-MAG antibodies showed deposits of IgM and C3 on the myelin sheaths, pronounced demyelination and widening of the myelin lamellae. In 4 of the patients with lower titers demyelination was absent or less pronounced.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540258     DOI: 10.1002/mus.880180709

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  11 in total

1.  Subclinical diabetic neuropathy with normal conventional electrophysiological study.

Authors:  Jong Seok Bae; Byoung Joon Kim
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

2.  Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.

Authors:  L Wang; M Chopp; A Szalad; Z Liu; M Bolz; F M Alvarez; M Lu; L Zhang; Y Cui; R L Zhang; Z G Zhang
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

Review 3.  Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.

Authors:  Norman Latov
Journal:  Nat Rev Neurol       Date:  2014-07-01       Impact factor: 42.937

Review 4.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

5.  Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients.

Authors:  T Maisonobe; B Chassande; M Vérin; M Jouni; J M Léger; P Bouche
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

6.  Anti-MAG/SGPG associated neuropathy does not commonly cause distal nerve temporal dispersion.

Authors:  F A A Gondim; E A De Sousa; N Latov; H W Sander; R L Chin; T H Brannagan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-12       Impact factor: 10.154

7.  Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations.

Authors:  Raffaele Iorio; Mario Sabatelli; Alessandra Del Grande; Giulia Bisogni; Valentina Damato; Domenico Plantone; Alessandro Marti; Giovanni Frisullo; Angela Romano; Paolo Maria Rossini; Marco Luigetti
Journal:  Neurol Sci       Date:  2014-09-06       Impact factor: 3.307

Review 8.  Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Authors:  Mazen M Dimachkie; Richard J Barohn; Jonathan Katz
Journal:  Neurol Clin       Date:  2013-02-16       Impact factor: 3.806

9.  Entrapment in anti myelin-associated glycoprotein neuropathy.

Authors:  Catharina G Faber; Nicolette C Notermans; John H J Wokke; Hessel Franssen
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

10.  Morphology of Donor and Recipient Nerves Utilised in Nerve Transfers to Restore Upper Limb Function in Cervical Spinal Cord Injury.

Authors:  Aurora Messina; Natasha Van Zyl; Michael Weymouth; Stephen Flood; Andrew Nunn; Catherine Cooper; Jodie Hahn; Mary P Galea
Journal:  Brain Sci       Date:  2016-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.